Capgemini Life Sciences and Healthcare

This October 10 at exactly 10AM CET, our panel is set to hit the stage at #BioTechX in Basel. Think of it as the next big binge-worthy blockbuster series, but – we’ll be honest – with more data and way fewer cliffhangers. Together with Sam Khalil, PhD, Robert McGregor and Alexander Krupp, Thorsten Alexander Rall will explore how innovative uses of clinical and operational data are transforming the pharma industry. Discover how these advancements make therapies more accessible and efficient. Learn from real-world examples and gain valuable insights into overcoming challenges and scaling solutions 📍 Basel, Switzerland 🗓️ October 10, 10AM CET Curious about the rest of the show, check out the full agenda here: https://lnkd.in/gHvAR2qS When you plan to be at #BioTechX, grab your popcorn and join us! 🍿🎥 #lifesciences #clinicaldevelopment #CapgeminiBioTechX

His heart rate went up...... His blood glucose suddenly dropped.... and his skin is sweaty. Nope, don’t worry, you are still on LinkedIn, and this is not the start of a thriller…this is all about biomarkers. We intuitively know that biological characteristics reveal information about our physiological state. Nowadays, we might even be tracking some digital statistics about the state of our bodies. But fitness tracking is just the tip of the iceberg. 🧊 Enter digital biomarkers....... Digital biomarkers offer powerful interpretations of a patient’s digital measurements and correlated medical conditions. They capture and analyze an array of physiological, behavioral, and environmental data through sensors, wearables, and digital platforms. 📊📱 What advantages might these insights bring? Think about spotting the onset of a disease before it arrives and rapidly evaluating the effect of treatment. Digital biomarkers will transform healthcare by driving innovations in disease prevention, diagnostics, treatment, and monitoring. 🏥💡 Read this point of view by Martin Page PhD, Camille Madelon, Sébastien Tourlet, PhD, Yousra Tourki, Sameera Singh and Kathryn ERNECQ to learn why digital biomarkers are game-changing for patients, healthcare professionals, and pharmaceutical companies. #biomarkers #lifesciences

New Blog Alert! Dive into our latest blog, “Pharma MES: What’s Happening Now and What’s Holding Us Back,” to explore the current state of Manufacturing Execution Systems (MES) in the pharmaceutical industry. Discover MES implementation's advancements, challenges, and future outlook, and how it can revolutionize operational efficiency, compliance, and product quality. Read the full blog here: https://bit.ly/3zfxc1b But that’s not all! We’re excited to announce our participation in the Pharma MES Berlin 2024 event. Join us to discuss the latest trends and innovations in MES and network with industry leaders. Event Details: Date: September 22-24, 2024 Location: Berlin, Germany Don’t miss this opportunity to connect and learn more about the future of MES in the pharma industry. Click here to learn more and schedule a meeting with our experts in advance: http://bit.ly/3WcKRyV See you there!   #manufacturing #digitaltransformation #industry40 #lifesciences

🌟 Check out our latest article on connected health 🌟 We are excited to share an article by our colleague, Rob Pears, following the release of our recent research paper on connected health. In the article, Rob Pears delves into the transformative impact of integrating healthcare and digital technology. From telemedicine and wearable devices to clinical decision support, connected health solutions are reshaping the Life Sciences industry. Our research shows that 63% of life sciences organizations are already offering or developing connected health products, with a sixfold increase in biopharma offerings since 2021. By 2028, connected health is expected to contribute 22% of industry revenue. However, with this growth comes the challenge of navigating data management, regulatory compliance, and skill gaps. Companies that establish a clear vision and strategic approach will be best positioned to lead in this new digital age. Read Rob's full article on pharmaphorum here: https://bit.ly/47mDs3N #ConnectedHealth #LifeSciences #DigitalHealth #Innovation #Healthcare

🚀 Exciting Announcement! 🚀 We’re thrilled to lead a panel discussion at BioTechX 2024 in Basel this October! 🎉 Join us as we explore how to use the FAIR Data Principles to Feed Scalable Generative AI Models.    Our panel, featuring Anastasios Moresis, Nikita Popov, Justin Melnick and James Hinchliffe will cover the following: 🔍 How FAIR Enables Generative AI: The synergy between FAIR data and AI. 🛡️ Addressing Adoption Fears: Overcoming concerns like hallucinations, security, and privacy. 🔄 Mutual Benefits: How generative AI can help implement FAIR data practices.   📅 Date: October 10  🕒 Time: 11:45 am CET Don’t miss this chance to hear from industry experts and connect with fellow professionals. Mark your calendars and stay tuned for more updates! The full conference calendar can be found here: https://bit.ly/4dYbPRh   #BioTechX2024 #FAIRData #GenerativeAI #Pharma #CapgeminiBioTechX24

🎉 Exciting News! 🎉 We are thrilled to announce that our colleague, Geoff McCleary, Global Connected Health Lead at Capgemini, is featured on the cover of Intelligent Health Tech magazine! 🏆 In the latest issue, Geoff shares his expert insights in the article discussing our report, “The Connected Health Revolution.” This report (you can download it here: https://lnkd.in/eaA4_ZcZ) delves into the rapid acceleration of connected health technologies, the transformative impact of AI, and the essential steps life sciences organizations (both pharma and medtech) need to take to navigate these changes effectively. Don’t miss out on this insightful article and discover more about our pioneering research: https://lnkd.in/e9Q2eTk5 #CapgeminiResearch #ConnectedHealth #LifeSciences #Innovation

🚀 Artificial Intelligence (AI) is revolutionizing the pharmaceutical industry, offering significant time and cost savings from research to market. However, this rapid adoption brings critical questions about model safety, robustness, ethics, and regulatory compliance. 👥 That’s why Malik B., Damien Hervault, Yousra Tourki, Raphael Viné and Barnabé Lecouteux have written two points of view around this topic. A short introduction: 🌟 In response, the concept of “trustworthy AI” is emerging as a necessity to ensure responsible development and use. The European AI Act, effective from August 1, 2024, introduces new requirements to ensure the safety of people and property. It also promotes innovation in testing techniques to manage bias and other risks associated with AI development. Enhanced technical documentation is now required for compliance assessment on multiple aspects, including robustness, transparency, and performance monitoring of AI systems, even post-deployment. 🌍 Similar trends are emerging globally, with specific adaptations for the pharmaceutical and life sciences industries at national and regional levels. 💡 Capgemini is leading this transition by anticipating these regulatory aspects and collaborating closely with our clients to develop a platform compliant with European AI legislation. Our approach, tailored to the regulated life sciences sector, ensures compliance with both general AI requirements and the rigorous standards and best practices specific to this industry. 📢 If you’re intrigued by this introduction, click here to download the full points of view: https://lnkd.in/gFqYcQqq #getthefutureyouwant #lifesciences #trustworthyAI #capgeminiinvent

🌟 Exciting News! 🌟 Capgemini is honored to be named a Leader in the 2024 ISG Provider Lens™ report for Life Sciences Digital Services, recognized across all five quadrants: - Clinical Development - Patient Engagement - Manufacturing Supply Chain - Pharmacovigilance and Regulatory Affairs — Digital Evolution - Commercial Operations — Digital Evolution 🔍 Spotlight on Patient Engagement 🔍 According to ISG, Capgemini leads in patient services digitization through immersive journey mapping and its Patient Engage Studio. Our comprehensive solutions ensure secure, compliant, and omnichannel healthcare experiences, optimizing efficiency and outcomes. ISG highlights our strong emphasis on personalized care, real-time data insights, and seamless interactions, which drive improved health outcomes and efficiency. 🏥💡 Discover more about our commitment to revolutionizing patient engagement and download the full report here: https://lnkd.in/e68iVsdF #LifeSciences #DigitalTransformation #PatientEngagement #HealthcareInnovation #Capgemini #ISGProviderLens

🌟 Join Us at Dreamforce 2024! 🌟 We are excited to announce that later this month, our team will be heading to San Francisco for #Dreamforce 2024. We are thrilled to host an exclusive session in the MOMA Atrium on September 17th: “Bring your Healthcare Professional (HCP) and Patient Experience to the Next Level with Salesforce.” In this session, Thorsten Alexander Rall Bibin Viyyath will explore how to deliver the best possible customer experiences through transformative technology. Drawing from our extensive experience in the Life Sciences industry, we will share insights on leveraging the Salesforce platform to revolutionize customer experience (CX) and meet the evolving expectations of HCPs and patients. Highlights of the session include: - Strategies to navigate changes in the Life Sciences market - A hands-on Salesforce demonstration showcasing improvements in disease management and treatment orchestration - Boosting HCP initiatives and patient engagement After the session, Thorsten Alexander Rall and Bibin Viyyath will be available to connect, answer your questions, and discuss how, together with Salesforce, we can transform patient outcomes and meet rising HCP and patient expectations. 📅 Date: September 17th 🕒 Time: 3:00 p.m. - 3:30 p.m. PST 📍 Location: MOMA Atrium (151 3rd St.), San Francisco Don’t miss this opportunity to connect with forward-thinking industry peers and learn more about the transformative power of Salesforce. Register now for our exclusive session: https://lnkd.in/dYcyXdzm For those attending Dreamforce, visit us at the Capgemini booth No. 1400 at the Moscone Center. We look forward to seeing you there! #Salesforce #Capgemini #Dreamforce2024 #LifeSciences #CustomerExperience #Healthcare

🌟 Get ready to witness the future of pharma and healthcare at BioTechX Europe 2024! 🌟 We’re beyond excited to be part of this groundbreaking event in Basel, Europe’s pharma hub, on October 9 and 10. Join us as we showcase our expertise in R&D, Clinical Development, GenAI, and pharma innovation. With 3,500+ attendees, 400+ speakers, and 50+ start-ups, this is THE go-to event for diagnostics, precision medicine, and digital transformation in pharma. Get ready for unparalleled networking opportunities and insights from top pharmaceutical and biotech companies. Explore the future with us - visit the link to find out more! https://lnkd.in/dGcQqSQd #BioTechX #PharmaInnovation #DigitalTransformation #Healthcare #ExploreTheFuture